/

2877.HK

SHINEWAY PHARMClosed

7.57−0.02 −0.33%HKD

HKSE · as of Oct 14, 04:08 ET · 15m delay

Open

7.59

Prev close

7.60

Day range

7.527.66

52-week range

7.1210.47

Volume

943.60K0.66×

Mkt cap

5.72B

P/E ttm

6.36

Fwd P/E

6.01

EPS ttm

1.19

Div yield

18.70%

Earnings

—

From 52w high

−27.70%

Price Chart

Yahoo Finance · delayed

2877.HKOct 14, 2026O 7.59H 7.66L 7.51C 7.57−0.02 (−0.33%)Vol 943.60K

SMA 508.03
SMA 2008.70

1Y change −12.08% since Oct 13, 2025 close529 bars loadedTimes in Asia/Hong_KongDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

2877.HK SHINEWAY PHARM · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: +2.64%
1 month: −6.20%
3 months: −8.69%
6 months: −23.92%
Year to date: −11.98%
1 year: −11.15%

Valuation & ownership

Market cap: 5.72B
Enterprise value: −1.49B
P/E (ttm): 6.36
Forward P/E: 6.01
PEG ratio: 0.28
Price / book: 0.59
Price / sales (ttm): 2.15
EV / EBITDA: -2.11
EPS (ttm): 1.19
EPS (forward): 1.26
Beta (5y monthly): 0.68
Dividend yield: 18.70%
Payout ratio: 50.59%
Shares outstanding: 755.40M
Float: 207.04M
Short % of float: —
Short ratio (days): —
Held by insiders: 66.31%
Held by institutions: 4.86%
Avg volume (3m): 1.42M
50-day average: 8.03
200-day average: 8.74
52-week change: −11.15%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 41.7
vs 50-day SMA: −5.69%
vs 200-day SMA: −12.98%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 3.39%
Realised vol (20d, ann.): 51.9%
From 52-week high: −27.70%
From 52-week low: +6.32%

ANR

Analyst Consensus

1 analysts

Consensus

—

Mean target

8.55

+12.90% implied

Low 8.55Median 8.55High 8.55

Recommendation trend

Now0 / 1 / 0

Buy / hold / sell counts

Financial Snapshot

Full statements →trailing twelve months

DES

About SHINEWAY PHARM

Yahoo Finance profile

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, chronic illnesses, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of Forway Investment Limited.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 2,656
Headquarters: Shijiazhuang, China
Website: shineway.com.hk
Officers: Mr. Zhenjiang Li Co-Founder & Executive Chairman
Mr. Huimin Li Executive Director
Mr. Bun Ching Lee Financial Controller & Company Secretary
Mr. King Kuen Hung AICPA, HKICPA, MBA

SEAS

Seasonality · 2877.HK

2007–2026 · monthly returns

Strongest month Nov +6.12%Weakest month Jul −5.47%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	10.0	-0.6	-4.6	8.2	-13.7	-11.9	10.6	1.7	0.5	-9.2			−12.0%
2025	-13.6	-0.1	-8.8	-4.9	5.2	2.9	6.8	3.3	-3.2	0.4	4.4	-1.9	−11.0%
2024	8.5	11.9	10.2	-4.8	-9.7	-8.0	4.9	8.4	6.1	-0.9	5.5	-0.5	+32.9%
2023	-3.8	-6.0	7.3	11.0	5.3	2.7	-2.9	-9.6	1.0	-11.5	-3.2	8.3	−4.2%
2022	0.4	-7.5	-2.0	2.7	-8.4	13.7	-6.9	-3.4	-19.4	-3.1	49.2	7.8	+10.2%
2021	3.2	2.9	-8.7	8.7	50.4	-5.7	-1.1	7.0	-12.1	1.4	-4.5	-3.8	+29.5%
2020	-8.4	0.6	-14.3	-1.2	-14.9	4.3	1.4	4.8	-10.5	0.2	9.0	0.2	−27.9%
2019	20.4	-10.3	-4.4	-0.3	-10.8	1.3	-7.2	11.1	-6.3	10.4	6.4	-8.1	−3.0%
2018	32.2	14.1	8.7	35.3	5.6	-10.2	-35.6	12.1	-3.4	-14.7	6.8	-21.9	+4.4%
2017	1.4	-6.2	1.6	10.7	-4.9	-11.7	-1.0	-8.7	-2.7	5.2	-2.1	1.8	−17.2%
2016	-10.4	3.7	1.9	-4.9	-7.0	2.5	-3.4	-0.6	-2.2	0.4	3.9	6.0	−10.9%
2015	3.2	-2.8	-0.3	12.1	2.9	-14.7	-14.5	-6.1	-3.7	12.5	0.2	-2.2	−16.1%
2014	7.9	5.1	12.5	0.3	4.6	-4.2	-4.4	3.4	-2.1	6.2	-5.7	-10.6	+10.9%
2013	8.2	-6.8	5.4	-1.0	8.1	-17.3	2.9	-5.4	-6.3	6.6	-6.8	-5.0	−18.9%
2012	1.5	30.1	-19.1	3.4	-2.0	-6.5	-1.1	6.0	-4.5	11.1	-6.0	12.3	+18.9%
2011	-11.8	13.7	-16.4	0.7	-2.3	-16.1	-14.5	-15.6	-13.3	14.1	-1.8	2.0	−50.6%
2010	-6.5	22.9	28.0	11.9	4.2	-4.2	-13.4	-1.4	34.1	-3.5	-4.5	-11.5	+53.4%
2009	0.5	0.5	0.0	7.7	30.8	26.3	-3.6	-3.8	14.3	31.3	22.0	9.3	+233.5%
2008	-5.5	-6.2	8.8	-5.0	12.0	0.2	-1.9	-1.8	-1.8	-47.3	44.8	3.8	−22.8%
2007	21.6	-2.9	0.8	2.8	14.5	-2.1	-8.4	-8.7	8.5	1.3	-1.2	0.9	+25.6%

2877.HK

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

2877.HK

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About SHINEWAY PHARM

Seasonality · 2877.HK

Insider Activity · 2877.HK

Congress Trades · 2877.HK

Investors Holding 2877.HK

Investors Holding 2877.HK

Congress Trades · 2877.HK

Insider Activity · 2877.HK

Seasonality · 2877.HK

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About SHINEWAY PHARM

Earnings & Dividends

News